The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
ER Stress Drives Lipogenesis and Steatohepatitis via Caspase-2 Activation of S1P
Open accessAbstract
Nonalcoholic fatty liver disease (NAFLD) progresses to nonalcoholic steatohepatitis (NASH) in response to elevated endoplasmic reticulum (ER) stress. Whereas the onset of simple steatosis requires elevated de novo lipogenesis, progression to NASH is triggered by accumulation of hepatocyte-free cholesterol. We now show that caspase-2, whose expression is ER-stress inducible and elevated in human and mouse NASH, controls the buildup of hepatic-free cholesterol and triglycerides by activating sterol regulatory element-binding proteins (SREBP) in a manner refractory to feedback inhibition. Caspase-2 colocalizes with site 1 protease (S1P) and cleaves it to generate a soluble active fragment that initiates SCAP-independent SREBP1/2 activation in the ER. Caspase-2 ablation or pharmacological inhibition prevents diet-induced steatosis and NASH progression in ER-stress-prone mice. Caspase-2 inhibition offers a specific and effective strategy for preventing or treating stress-driven fatty liver diseases, whereas caspase-2-generated S1P proteolytic fragments, which enter the secretory pathway, are potential NASH biomarkers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“A study showed that ER-stress-mediated SREBP1/2 activation, TG and cholesterol accumulation, as well as MASH progression, all depend on Casp2 [91].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [91]
In the citing paper
“Thus, ER stress might contribute to the development of increased hepatic DNL in hepatic IR, at least in the advanced stages of MASLD/MASH [91].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [91]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Improved vectors and genome-wide libraries for CRISPR screening
Sanjana, N. E., Shalem, O., & Zhang, F. (2014) · Nature Methods · doi:10.1038/nmeth.3047 · Cited by 5,239
Obesity induces a phenotypic switch in adipose tissue macrophage polarization
Lumeng, C. N., Bodzin, J. L., & Saltiel, A. R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29881 · Cited by 4,664
Self-citationBrown, M. S., & Goldstein, J. L. (1997) · Cell · doi:10.1016/s0092-8674(00)80213-5 · Cited by 3,834
Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis
Tilg, H., & Moschen, A. R. (2010) · Hepatology · doi:10.1002/hep.24001 · Cited by 2,548
Human Fatty Liver Disease: Old Questions and New Insights
Cohen, J. C., Horton, J. D., & Hobbs, H. H. (2011) · Science · doi:10.1126/science.1204265 · Cited by 2,089
A lipidomic analysis of nonalcoholic fatty liver disease
Puri, P., Baillie, R. A., Wiest, M. M., Mirshahi, F., Choudhury, J., Cheung, O., Sargeant, C., Contos, M. J., & Sanyal, A. J. (2007) · Hepatology · doi:10.1002/hep.21763 · Cited by 1,338
Feldmann, H. M., Golozoubova, V., Cannon, B., & Nedergaard, J. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2008.12.014 · Cited by 1,318
Loomba, R., Seguritan, V., Li, W., Long, T., Klitgord, N., Bhatt, A., Dulai, P. S., Caussy, C., Bettencourt, R., Highlander, S. K., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.04.001 · Cited by 1,123
Self-citationLambert, J. E., Ramos–Roman, M. A., Browning, J. D., & Parks, E. J. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.11.049 · Cited by 1,069 · cited 1×
“One metabolic process thought to initiate NAFLD is de novo lipogenesis (DNL), whose rate is up to 3-fold higher in NAFLD patients (Lambert et al., 2014).”
Regulation of Hepatic Lipogenesis by the Transcription Factor XBP1
Lee, A., Scapa, E. F., Cohen, D. E., & Glimcher, L. H. (2008) · Science · doi:10.1126/science.1158042 · Cited by 1,000
Cited by
Sorted by citations
Items 201–300 of 332
Chen, F., Yang, A., Lu, Y., Zhang, Y., Zhang, J., Bu, J., Guo, R., Han, Y., Wu, D., & Wu, Y. (2025) · Nature Communications · doi:10.1038/s41467-025-56620-4 · Cited by 13
Park, S., Jeong, I., & Kim, O. (2025) · Nutrients · doi:10.3390/nu17101682 · Cited by 12
Emerging therapeutic targets for NASH: key innovations at the preclinical level
Horn, P., & Newsome, P. N. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1728742 · Cited by 12
CDKN1A and EGR1 are key genes for endoplasmic reticulum stress-induced ferroptosis in MASH
Xu, Q., Chen, Y., Zhang, H., Zhou, K., Zhao, Y., Deng, W., Wang, Z., Guo, L., Liu, H., Ren, Z., et al. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.05.413 · Cited by 12
The Lipid-Oxidative Stress Axis: Novel Therapeutic Targets for Podocytopathy
Liu, Y., Zou, M., & Wang, Y. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s530737 · Cited by 13
Huang, Z., Zheng, X., Chen, Z., Zheng, Z., Yao, D., Yang, S. K., Zhang, Y., & Aweya, J. J. (2023) · Marine Drugs · doi:10.3390/md21030164 · Cited by 11
UBXN1 maintains ER proteostasis and represses UPR activation by modulating translation
Ahlstedt, B. A., Ganji, R., Mukkavalli, S., Paulo, J. A., Gygi, S. P., & Raman, M. (2024) · EMBO Reports · doi:10.1038/s44319-023-00027-z · Cited by 12
The mechanism of DEHP-induced lipid accumulation in liver of female zebrafish
Mi, Y., Shi, J., Ma, X., Wei, D., Liu, R., Samra, Yuan, C., Qi, Y., & Huang, D. (2024) · Environmental Pollution · doi:10.1016/j.envpol.2024.125455 · Cited by 11
A Diet High in Fat and Fructose Induces Early Hepatic Mitochondrial Aging
Bramlage, K., Bhattacharjee, J., Kirby, M., Myronovych, A., Gupta, R., Salazar-Gonzalez, R.-M., Xanthakos, S. A., Bove, K. E., & Kohli, R. (2021) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000003068 · Cited by 11
Deng, S., Ge, Y., Zhai, Z., Liu, H., Zhang, X., Chen, Y., Yang, Y., & Wu, Z. (2024) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2024.109635 · Cited by 10
High-fat-diet-induced hepatic insulin resistance per se attenuates murine de novo lipogenesis
Goedeke, L., Strober, J. W., Suh, R., Paolella, L. M., Li, X., Rogers, J. C., Petersen, M. C., Nasiri, A. R., Casals, G., Kahn, M., et al. (2024) · iScience · doi:10.1016/j.isci.2024.111175 · Cited by 10
Knockdown of hepatic mitochondrial calcium uniporter mitigates MASH and fibrosis in mice
Li, S., Chen, F., Liu, M., Zhang, Y., Xu, J., Li, X., Shang, Z., Huang, S., Song, S., & Tu, C. (2024) · Cell & Bioscience · doi:10.1186/s13578-024-01315-4 · Cited by 10
Cholesterol metabolism: A strategy for overcoming drug resistance in tumors
Li, J., Guo, Y., Zhang, W., Xia, M. H., Liu, G., Sun, Y. P., Liu, C. X., & Zhong, J. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.116974 · Cited by 10
Lequoy, M., Gigante, E., Couty, J., & Desbois‐Mouthon, C. (2020) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2019-0044 · Cited by 12
Zhang, D., Niu, S.-Z., Ma, Y., Chen, H., Yu, W., Li, M., Zhou, B., Deng, Y., Shi, C., Pu, G., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.770652 · Cited by 10
AIBP, Angiogenesis, Hematopoiesis, and Atherogenesis
Qiu, X., Luo, J.-M., & Fang, L. (2020) · Current Atherosclerosis Reports · doi:10.1007/s11883-020-00899-9 · Cited by 11
Li, G., Xing, Z., Wang, W., Luo, W., Ma, Z., Wu, Z., Chen, H., Li, Y., Wang, C., Zeng, F., et al. (2021) · Experimental Cell Research · doi:10.1016/j.yexcr.2021.112548 · Cited by 12
Yang, J., He, L., Gao, M., Xiao, F., Zhang, F., Wang, S., Yang, S., Ye, X., Qu, W., Li, L., et al. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154777 · Cited by 10
Ahn, S. H., Lee, Y.-J., Lim, D. S., Cho, W., Gwon, H. J., El‐Aty, A. M. A., Jeong, J. H., & Jung, T. W. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.150829 · Cited by 11
Peña-de-la-Sancha, P., Wieser, B. I., Schauer, S., Reicher, H., Sattler, W., Breinbauer, R., Schweiger, M., Lechleitner, M., Frank, S., Zechner, R., et al. (2025) · Communications Biology · doi:10.1038/s42003-025-08002-1 · Cited by 15
Therapeutic strategies targeting SREBP transcription factors: an update to 2024
Wang, Y., Xiao, H., Lai, L., & Zheng, Z. (2025) · Acta Materia Medica · doi:10.15212/amm-2025-0001 · Cited by 11
Zhang, G., & Sun, J. (2022) · Journal of Immunology Research · doi:10.1155/2022/1366508 · Cited by 10
Role of the FOXM1/CMA/ER stress axis in regulating the progression of nonalcoholic steatohepatitis
Ma, S., Xia, E., Zhang, M., Hu, Y., Tian, S., Zheng, X., Li, B., Ma, G., Su, R. J., Sun, K., et al. (2025) · Clinical and Translational Medicine · doi:10.1002/ctm2.70202 · Cited by 8
The Ways to Die: Cell Death in Liver Pathophysiology
Cao, P., Jaeschke, H., Ni, H., & Ding, W. (2025) · Seminars in Liver Disease · doi:10.1055/a-2576-4332 · Cited by 11
Golgi mechanics controls lipid metabolism
Théry, M., & Pende, M. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0289-2 · Cited by 9
StarD5 levels of expression correlate with onset and progression of steatosis and liver fibrosis
Kakiyama, G., Minoiwa, K., Bai-Kamara, N., Hashiguchi, T., Pandak, W. M., & Rodríguez‐Agudo, D. (2024) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00024.2024 · Cited by 9
Xu, J., Wu, T., Lam, S. M., Shui, G., Yang, S., Wang, Y., & Tao, C. (2024) · Agriculture · doi:10.3390/agriculture14050658 · Cited by 8
Vlahopoulos, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168621 · Cited by 9
Liu, Y., Zienkiewicz, J., Boyd, K. L., Smith, T. E., Xu, Z., & Hawiger, J. (2021) · Scientific Reports · doi:10.1038/s41598-021-91395-w · Cited by 8
Bian, C., Sun, J. H., Huang, X., Ji, S., & Ji, H. (2022) · Fish Physiology and Biochemistry · doi:10.1007/s10695-021-01031-7 · Cited by 8
Endoplasmic Reticulum Stress Signaling in the Regulation of Hepatic Pathological Responses
Baral, A. (2024) · Stresses · doi:10.3390/stresses4030031 · Cited by 8
Site-1 protease inhibits mitochondrial respiration by controlling the TGF-β target gene Mss51
Mousa, M. G., Vuppaladhadiam, L., Kelly, M. O., Pietka, T., Ek, S., Shen, K. C., Meyer, G. A., Finck, B. N., & Brookheart, R. T. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112336 · Cited by 8
Long-term effects on liver metabolism induced by ceftriaxone sodium pretreatment
Lai, C., Chen, L., Zhong, X., Tang, Z., Zhang, B., Luo, Y. H., Li, C., Jin, M., Chen, X., Li, J., et al. (2023) · Environmental Pollution · doi:10.1016/j.envpol.2023.122238 · Cited by 7
Role of cholesterol homeostasis in MASH-driven hepatocellular carcinoma: not just a neutral fat
Ribas, V. (2024) · Exploration of Digestive Diseases · doi:10.37349/edd.2024.00048 · Cited by 8
Liu, Y., Veach, R. A., Zienkiewicz, J., Boyd, K. L., Smith, T. E., Xu, Z., Wylezinski, L. S., & Hawiger, J. (2019) · ImmunoHorizons · doi:10.4049/immunohorizons.1900064 · Cited by 7
Quantum Mechanics/Molecular Mechanics Study on Caspase-2 Recognition by Peptide Inhibitors
Mitrašinović, P. M. (2020) · Acta chimica slovenica · doi:10.17344/acsi.2020.5847 · Cited by 7
A new SPRING in lipid metabolism
Hendrix, S., & Zelcer, N. (2023) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000894 · Cited by 8
Lipotoxicity, ER Stress, and Cardiovascular Disease: Current Understanding and Future Directions
Shreya, S., Alam, M. J., Anupriya, Jaiswal, S., Rani, V., & Jain, B. P. (2023) · Cardiovascular & Hematological Agents in Medicinal Chemistry · doi:10.2174/0118715257262366230928051902 · Cited by 6
Liver fibrosis pathologies and potentials of RNA based therapeutics modalities
Diwan, R., Gaytan, S. L., Bhatt, H. N., Pena‐Zacarias, J., & Nurunnabi, M. (2024) · Drug Delivery and Translational Research · doi:10.1007/s13346-024-01551-8 · Cited by 6
Cui, Y., Wang, Q., Chang, R., Aboragah, A. A., Loor, J. J., & Xu, C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.789430 · Cited by 6
Battling IL-17, the troublemaker in alcohol-induced hepatocellular carcinoma
Bansal, R. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.02.011 · Cited by 6
Overeating: A Conundrum of Lipid Metabolism and Inflammation in Obesity and Cancer
Surumbayeva, A., Saiman, Y., & Astsaturov, I. A. (2025) · Journal of Cellular Physiology · doi:10.1002/jcp.70104 · Cited by 5
AGR2: The Covert Driver and New Dawn of Hepatobiliary and Pancreatic Cancer Treatment
Qu, S., Jia, W.-L., Nie, Y., Shi, W., Chen, C., Zhao, Z.-H., & Song, W. (2024) · Biomolecules · doi:10.3390/biom14070743 · Cited by 6
Inhibition of LPCAT3 exacerbates endoplasmic reticulum stress and HBV replication
Shi, S., Zhang, H., Jiang, P., Zhou, Y., Zhu, Y., Feng, T., Xie, C., He, H., & Chen, J. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113337 · Cited by 5
Treating metabolic dysfunction‐associated steatohepatitis: The fat‐trimming FGF21 approach
Li, X., Rao, Z., Hu, W., Lu, W., & Luo, Y. (2024) · Obesity Reviews · doi:10.1111/obr.13861 · Cited by 6
Prognostic Role of Unfolded Protein Response-Related Genes in Hepatocellular Carcinoma
Zhang, S., Li, X., Zheng, Y., Hu, H., Liu, J., Zhang, S., Tang, C., Mo, Z., & Kuang, W. (2023) · Current Protein and Peptide Science · doi:10.2174/1389203724666230816090504 · Cited by 5
Liu, C., Miyahara, H., Dai, J., Cui, X., Li, Y., Kang, X., Higuchi, K., & Mori, M. (2021) · Experimental Eye Research · doi:10.1016/j.exer.2021.108905 · Cited by 5
Xeroderma pigmentosum protein XPD controls caspase-mediated stress responses
Wei, H., Weaver, Y. M., & Weaver, B. P. (2024) · Nature Communications · doi:10.1038/s41467-024-53755-8 · Cited by 4
Recent Progress of Sterol Regulatory Element-binding Proteins Role in Atherosclerosis
Zou, A., Sun, Y., Dong, W., Lu, J., & Yang, Z. (2025) · Current Atherosclerosis Reports · doi:10.1007/s11883-025-01317-8 · Cited by 5
Huang, H., Wang, Y., Chen, F., Zhao, A., He, W., & Li, M. (2025) · Functional & Integrative Genomics · doi:10.1007/s10142-025-01694-y · Cited by 4
Huang, Y., Ding, Y., Guo, X., Huang, L., Meng, X., Jiang, W., Wang, Z., Yang, T., Zheng, M., & Tan, X. (2025) · Lipids in Health and Disease · doi:10.1186/s12944-025-02761-w · Cited by 4
Guo, J., Zhang, F., Zhang, Y., & Wang, Y. (2025) · Food & Function · doi:10.1039/d3fo04374f · Cited by 4
Hirao, H., Kageyama, S., Nakamura, K., Kadono, K., Kojima, H., Siyuan, Y., Farmer, D. G., Kaldas, F. M., Dery, K. J., & Kupiec‐Weglinski, J. W. (2023) · Frontiers in Transplantation · doi:10.3389/frtra.2023.1176384 · Cited by 4
Zhang, J., Liu, Z., Yin, X., Wang, E., & Wang, J. (2023) · iScience · doi:10.1016/j.isci.2023.108614 · Cited by 6
Species differences of fatty liver diseases: comparisons between human and feline
Ling, L., Li, R., Xu, M., Zhou, J., Hu, M., Zhang, X., & Zhang, X.-J. (2024) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00014.2024 · Cited by 5
Chen, F., & Liu, B. (2021) · Nutrition · doi:10.1016/j.nut.2021.111531 · Cited by 4
Manifold Roles of Ceramide Metabolism in Non-Alcoholic Fatty Liver Disease and Liver Cancer
Wang, K., Wei, Y., Xu, R., Li, Y., & Mao, C. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-981-19-0394-6_11 · Cited by 4
Yu, W., Jiang, H., Liu, F., Li, Z., Xu, L., Liu, C., Lv, W., Wang, J., Gao, Y., Liang, S., et al. (2022) · Animals · doi:10.3390/ani12223070 · Cited by 4
Deciphering significances of autophagy in the development and metabolism of adipose tissue
Liu, Z., Peng, H., Liu, P., Duan, F., Yang, Y., Li, P., Li, Z., Wu, J., Chang, J., Shang, D., et al. (2025) · Experimental Cell Research · doi:10.1016/j.yexcr.2025.114478 · Cited by 3
Boonloh, K., Lee, E. Y., Jo, S. H., Park, N. W., Lee, S. B., & Chung, C. H. (2025) · Scientific Reports · doi:10.1038/s41598-025-23626-3 · Cited by 3
Dual-channel fluorescent probe for real-time monitoring of ER viscosity and polarity under stress
Athul, K. K., Pal, S., Bera, A., Das, P. K., & Bhuniya, S. (2025) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2025.139361 · Cited by 3
Caspase-2 in liver disease and hepatocellular carcinoma
López-Pascual, A., Cusachs, M., Arechederra, M., Berasain, C., Herrero, C., Avila, M. A., & Fernández‐Barrena, M. G. (2022) · Exploration of Digestive Diseases · doi:10.37349/edd.2022.00007 · Cited by 3
Wang, Y., Yu, H., Cen, Z., Zhu, Y., & Wu, W. (2023) · Metabolism Open · doi:10.1016/j.metop.2023.100267 · Cited by 3
Ally or traitor: the dual role of p62 in caspase-2 regulation
Volik, P. I., Zamaraev, A. V., Egorshina, A. Y., Pervushin, N. V., Kapusta, A. A., Tyurin‐Kuzmin, P. A., Lipatova, A. V., Kaehne, T., Lavrik, I. N., Zhivotovsky, B., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-07230-3 · Cited by 3
Zhao, J., Jin, J., Li, Y., Zhang, S., Li, F., Cui, J., Wang, Z., Yan, D., & Qiu, F. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.119318 · Cited by 3
Park, S., Helsley, R. N., Fadhul, T., Willoughby, J. L. S., Noetzli, L. J., Tu, H.-C., Solheim, M. H., Fujisaka, S., Pan, H., Dreyfuss, J. M., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.27.525605 · Cited by 3
Sequential PIDD1 auto-processing is essential for ploidy control in the liver and heartPreprint
Eichin, F., Sladky, V. C., Reiner, M. A., Leone, M., Abila, E., Rendeiro, A. F., Böttcher, R. T., Dahlhoff, M., Kolbe, T., & Villunger, A. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.23.660994 · Cited by 3
Bhadury, R., Athar, M., Mishra, P., Gogoi, C., Sharma, S., & Ghorpade, D. S. (2025) · Cells · doi:10.3390/cells14050372 · Cited by 2
Liu, M., Zhang, L.-K., Zhu, K.-C., Guo, H., Zhu, T., Liu, B.-S., Zhang, N., & Zhang, D. (2025) · Marine Life Science & Technology · doi:10.1007/s42995-025-00324-7 · Cited by 2
Chen, S., Dong, L., Shan, Y., Chen, Z., Xia, Y., Liu, J., Liu, D., Yang, G., Yang, M., & Li, K. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27031213 · Cited by 2
Luo, Y., Zhang, Y., Zhang, Q., Li, X., Cai, K., Xu, Y., Zhao, R., Zhang, S., Bai, X., Chen, H., et al. (2026) · Hepatology Communications · doi:10.1097/hc9.0000000000000975 · Cited by 3
Molecular mechanisms and pathogenesis of MASH
Gallage, S., Govaere, O., Anstee, Q. M., Shulman, G. I., Tacke, F., & Heikenwälder, M. F. (2026) · Nature · doi:10.1038/s41586-026-10529-0 · Cited by 3
Dang, R., Wang, J., Tang, M., Han, W., & Jiang, P. (2023) · Advanced Biology · doi:10.1002/adbi.202300228 · Cited by 2
Cordier, P., Sangouard, F., Fang, J., Kaboré, C., Desdouets, C., & Celton‐Morizur, S. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-3694-7_3 · Cited by 2
PIDDosome-induced p53-activation for ploidy restriction facilitates hepatocarcinogenesisPreprint
Sladky, V. C., Knapp, K., Szabo, T., Bongiovanni, L., van den Bos, H., Spierings, D., Westendorp, B., Stojaković, T., Scharnagl, H., Timelthaler, G., et al. (2020) · bioRxiv · doi:10.1101/2020.05.13.092486 · Cited by 1
Kumar, J., Tyagi, P., Saini, A. K., Sharma, D., Maras, J. S., & Kumar, V. (2023) · Preprints.org · doi:10.20944/preprints202305.1517.v1 · Cited by 2
Thiourea Derivatives Rejuvenate Dysfunctional Mitochondria in Chronic Hepatitis B InfectionPreprint
Kumar, J., Tyagi, P., Saini, A. K., Sharma, D., Maras, J. S., & Kumar, V. (2023) · Preprints.org · doi:10.20944/preprints202305.1517.v2 · Cited by 2
Horn, P., & Tacke, F. (2021) · Translational Gastroenterology and Hepatology · doi:10.21037/tgh-22-65 · Cited by 2
Cap CASP, not SCAP, to fight steatohepatitis
Goessling, W. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.09.014 · Cited by 1
Validation of the Intermolecular Disulfide Bond in Caspase-2
Amason, M. E., Li, L., Harvest, C. K., Lacey, C. A., & Miao, E. A. (2024) · Biology · doi:10.3390/biology13010049 · Cited by 1
Fuller, J. L., Shi, K., Pockes, S., Finzel, B. C., Ashe, K. H., & Walters, M. A. (2025) · ACS Chemical Biology · doi:10.1021/acschembio.4c00795 · Cited by 1
Location, location, location: Cholesterol in lipid droplets as a driver of MASH progression
Wang, X., & Tabas, I. A. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2509899122 · Cited by 1
Cho, R., Shih, Y., Lien, C., Huang, Y., Lien, P.-Y., Lin, C., Lin, F.-Y., Tsai, C., & Chen, S. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.168016 · Cited by 1
Cai, G., Cui, X., Li, W., Huang, S., & Peng, W. (2025) · Annals of Medicine · doi:10.1080/07853890.2025.2566872 · Cited by 2
Dorstyn, L., Lim, Y. P., Scanlan, J., McLennan, E. D., Bellis, D. D., Katschner, M., Finnie, J. W., Emery‐Corbin, S. J., Yousef, J. M., Dagley, L. F., et al. (2026) · Science Advances · doi:10.1126/sciadv.aeb2571 · Cited by 1
Wang, Z., Fu, Y., Zheng, W., Zeng, X., Xu, Z., Chen, J., Liu, X., & Qin, H. X. (2026) · Phytotherapy Research · doi:10.1002/ptr.70252 · Cited by 1
Markaide, E., Izquierdo‐Sánchez, L., Olaizola, I., Urretabizkaia-Garmendia, J., de Gauna, M. R., Buqué, X., Lasa-Elosegi, I., Lapitz, A., Bais, T., Val, B., et al. (2026) · Hepatology · doi:10.1097/hep.0000000000001711 · Cited by 1
Jiang, J., He, M., Li, B., Xiong, Y., Shi, H., Huang, Y., Xu, D., & Zhang, J. (2026) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2026.119970 · Cited by 1
Cholesterol–LXR axis in metabolic regulation of liver fibrosis and hepatocarcinogenesis
Piccinin, E., Villani, G., & Moschetta, A. (2026) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2026.03.011 · Cited by 1
IL-17 Signaling Promotes Excessive Alcoholic Liver Disease and Excessive Alcohol Drinking in Mice
Brenner, D. A., & Ikejima, K. (2021) · Juntendō Igaku/Juntendo igaku · doi:10.14789/jmj.jmj21-p02 · Cited by 1
Jasper, L. A., & Wang, M. C. (2024) · Nature Metabolism · doi:10.1038/s42255-023-00946-0 · Cited by 1
From fatty liver to nonalcoholic steatohepatitis with fibrosis
Muriel, P. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99764-5.00013-5 · Cited by 1
Aspects immuno-inflammatoires de la stéatohépatite métabolique
Blanc, M., & Gautier, E. L. (2023) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2023.03.012 · Cited by 1
JMJD4-demethylated RIG-I prevents hepatic steatosis and carcinogenesisPreprint
Li, Z., Zhou, Y., Jia, K., Yang, Y., Zhang, L., Wang, S., Wang, M., Li, Y., Li, N., Yu, Y., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-410612/v1 · Cited by 1
Zhang, G. (2021) · Research Square · doi:10.21203/rs.3.rs-818967/v1 · Cited by 1
Endoplasmic Reticulum Stress in Disease
Kaufman, R. J., Deng, R., Huang, T. Y., Lebeaupin, C., Yong, J., & Popolo, L. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821618-7.00129-2 · Cited by 1
Self-citationChemoproteomics identifies proteoform-selective caspase-2 inhibitorsPreprint
Castellón, J. O., Ofori, S., Armenta, E., Burton, N. R., Boatner, L. M., Takayoshi, E. E., Faragalla, M., Zhou, A., Tran, K., Shek, J., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.25.563785 · Cited by 1
Lebeaupin, C., Donahue, K. L., Lal, S., Christensen, S. M., Asano, S., Wadsworth, M. H., Bound, K., De, S., McMahon, J., Schlerman, F., et al. (2025) · bioRxiv (preprint) · doi:10.64898/2025.12.17.694415
Jacotot, E. D. (2020) · médecine/sciences · doi:10.1051/medsci/2020222 · Cited by 8
Wang, H., & Liu, R. (2019) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14220
Metadata
- Authors
- Kim, J. Y., Garcia-Carbonell, R., Yamachika, S., Zhao, P., Dhar, D., Loomba, R., Kaufman, R. J., Saltiel, A. R., & Karin, M.
- Affiliations
- University of California San Diego (US)
- Sanford Burnham Prebys Medical Discovery Institute (US)
- Corresponding author
- Karin, Michael
- ORCID
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2018-09
- Volume
- 175
- Issue
- 1
- Pages
- 133-145.e15
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC6159928
- OpenAlex
- W2890819762
- Cited by
- 333
- References
- 59
- Citations by year
- 2026: 16 · 2025: 45 · 2024: 48 · 2023: 49 · 2022: 49 · 2021: 49 · 2020: 49 · 2019: 24 · 2018: 4
- FWCI
- 24.60
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- NIH
- NCI (R01CA211794, R01CA198103, R01CA155120)
- NIEHS (P42ES010337)
- NHMRC (APP112227)
- AACR-Bayer Hepatocellular Carcinoma Fellowship (16-40-44-KIMJ)
- Diabetes Research Center Pilot and Feasibility Grant (P30DK063491)
- Boehringer Ingelheim Fonds
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- endoplasmic reticulum stress, nonalcoholic steatohepatitis, non-alcoholic fatty liver disease, caspase-2, site-1 protease, de novo lipogenesis, hepatic steatosis, free cholesterol accumulation, triglyceride accumulation
- MeSH terms
- Animals, Cholesterol, Endoplasmic Reticulum, Fatty Liver, Humans, Liver, Mice, Inbred C57BL, Serine Endopeptidases, Triglycerides, Hepatocytes, Proprotein Convertases, Lipogenesis, Mice, Sterol Regulatory Element Binding Protein 1, Caspase 2, HEK293 Cells, Endoplasmic Reticulum Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review